3/27
10:20 am
rare
Rating for RARE
Low
Report
Rating for RARE
2/26
08:58 am
rare
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $118.00 price target on the stock.
Low
Report
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $118.00 price target on the stock.
2/26
08:52 am
rare
Rating for RARE
Low
Report
Rating for RARE
2/18
06:50 am
rare
Rating for RARE
Low
Report
Rating for RARE
2/14
08:07 am
rare
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $95.00 price target on the stock.
Low
Report
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $95.00 price target on the stock.
1/22
11:24 am
rare
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $118.00 price target on the stock.
Low
Report
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $118.00 price target on the stock.
1/22
11:11 am
rare
Rating for RARE
Low
Report
Rating for RARE
1/13
10:04 am
rare
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $48.00 price target on the stock, up previously from $46.00.
Medium
Report
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $48.00 price target on the stock, up previously from $46.00.
1/13
10:04 am
rare
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $48.00 price target on the stock, up previously from $46.00.
Medium
Report
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $48.00 price target on the stock, up previously from $46.00.
1/13
09:37 am
rare
Rating for RARE
Low
Report
Rating for RARE
1/13
09:37 am
rare
Rating for RARE
Low
Report
Rating for RARE